References
- Brewerton D A, Caffrey M, Hart F D, James J CO, Nicolls A, Sturrock RD. Ankylosing spondylitis and HLA-B27. Lancet 1973; i: 904–7
- Schlosstein L, Terasaki P I, Bluestone R, Pearson CM. High association of a HLA antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288: 704–6
- Ebringer A. The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis. Br J Rheumatol 1983; 22: 53–66, Suppl 2
- Geczy A F, Prendergast J K, Sullivan J S, Upfold L I, Edmonds J P, Bashir HV. Possible role of enteric organisms in the pathogenesis of seronegative arthropathies. The spondyloarthropathies. Vol 9. Advances in inflammation research, M Ziff, S B Cohen. Raven Press, New York 1985; 129–38
- Seager K, Bashir H V, Geczy A F, Edmonds J P, De Vere, Tyndall A. Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature 1979; 277: 68–70
- Druery C, Bashir H V, Geczy A F, Alexander K, Edmonds JP. Search for Klebsiella cell wall components cross-reactive with lymphocytes of B27+AS+-individuals. Human Immunol 1980; 1: 151–60
- Geczy A F, Alexander K, Bashir H V, Edmonds J P, Sullivan JS. HLA-B27, Klebsiella and ankylosing spondylitis: Biological and chemical studies. Immunol Rev 1983; 70: 23–50
- Archer J R, Stubbs M M, Currey H LF, Geczy AF. Antiserum to Klebsiella K43 BTS 1 specially lyses lymphocytes of HLA-B-27-positive patients with ankylosing spondylitis from a London population. Lancet 1985; i: 344–5
- Geczy A F, van Leeuwen A, van Rood J J, Ivanyi P, Cats A. Blind confirmation in Leiden of Geczy factor on the cells of Dutch patients with ankylosing spondylitis. Human Immunol 1986; 17: 239–45
- Archer J R, Stubbs M M, Geczy AF. Factors influencing the cytotoxicity of anti-bacterial sera for lymphocytes from ankylosing spondylitis patients. Clin Exptl Rheumatol 1988; 6: 35–9
- Beukelman C J, van Leeuwen A, Aerts PC, et al. Rabbit antisera to enterobacteriaceae isolated from HLA-B27 positive patients with ankylosing spondylitis (AS) are lytic for the mononuclear cells of AS patients. Br J Rheumatol 1988; 27: 58–60, Suppl II
- Bruning J F, Douglas R, Scholtus M, Van Rood JJ. Automatic reading and recording of the microlymphocytotoxicity test. Tissue Antigens 1972; 2: 473–77
- Bruning J F, Kardol M J, Arentzen R. Carboxyfluorescein mediated lympholysis. J Immunol Methods 1980; 33: 33–34
- Allison C, Byars NE. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods 1986; 95: 157–68
- Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990; 11: 137–42